Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.
Qin R, Fan X, Huang Y, Chen S, Ding R, Yao Y, Wu R, Duan Y, Li X, Khan HU, Hu J, Wang H.
Qin R, et al. Among authors: khan hu.
Transl Oncol. 2024 Dec;50:102156. doi: 10.1016/j.tranon.2024.102156. Epub 2024 Oct 13.
Transl Oncol. 2024.
PMID: 39405607
Free article.
Review.